A Pilot Study of Suvorexant for Insomnia in Parkinson Disease

Summary

The purpose of this study is to see if the study drug, suvorexant, is safe and effective in treating symptoms of insomnia in people with Parkinson's Disease. It is anticipated that a total of 20 subjects, 30 to 80 years of age, with Parkinson's Disease and symptoms of insomnia will participate in the study at this site

Timeline

Start

2016-04

Primary completion

2022-04

Completion

2022-04

Drugs

Indications